Skip to main content

Free Webinar Now Available On Demand: Ready-To-Use primary packaging for flexible aseptic operations

Free Webinar Now Available On Demand:
Ready-To-Use primary packaging for flexible aseptic operations

How to gain speed to the market with a multi-sourcing approach

 

Free Webinar Now Available On Demand: Why pharma packaging choice matters in protecting children’s lives?

Free Webinar Now Available On Demand: Why pharma packaging choice matters in protecting children’s lives?

 

An evaluation of current and future trends in the pharmaceutical industry

The Pharmaceutical Post - SGD Pharma actualités

Source : The Pharmaceutical Post - N°6 - Mai 2021

Protéger les enfants grâce à des emballages certifiés CRC (Child Resistant Closure)

Tendances actuelles et futures en matière d'emballages à l'épreuve des enfants dans l'industrie pharmaceutique.

 

SGD Pharma enrichit son offre Sterinity, flacons en verre moulé prêt à l’emploi, du format 50 ml ISO & EasyLyo, en verre jaune, disponible en barquette

Webinar - Ready-to-use primary packaging for flexible aseptic operations

Webinar - Why pharma packaging choice matters in protecting children's lives ?

Sucy-en-Brie plant celebrated the first furnace lighting ceremony in 10 years

Sucy-en-Brie plant celebrated the first furnace lighting ceremony in 10 years – the result of weeks of hard work modernizing the furnace as part of SGD Pharma’s Sucy Pharma 2025 project.

SGD Pharma fait évoluer sa gamme de Type I, en réponse aux besoins du marché, avec l’amélioration de son offre de produits et de services

Renforcer sa proposition de valeur représente une nouvelle étape dans l'engagement de SGD Pharma pour l’excellence et la qualité

COVID-19 Container Closure System and Component Changes: Glass Vials and Stoppers

Guidance for Industry - March 2021

This guidance represents the current thinking of the Food and Drug Administration (FDA or Agency) on this topic. It does not establish any rights for any person and is not binding on FDA or the public. You can use an alternative approach if it satisfies the requirements of the applicable statutes and regulations. To discuss an alternative approach, contact the FDA staff or Office responsible for this guidance as listed on the title page.

S'abonner à